Multitarget stool DNA tests show higher sensitivity for colorectal cancer and advanced adenomas than FIT, but with lower specificity and higher costs; further evidence is needed on long-term effectiveness and economic sustainability. (Clinical Endoscopy)
Stool DNA Tests Offer Higher Sensitivity but Lower Specificity Than FIT
The CRC Digest